- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterBladder Cancer
|
Comparative Sensitivity of Urinary Cyfra 21-1, Urinary Bladder Cancer Antigen, Tissue Polypeptide Antigen and NMP22 to Detect Bladder Cancer
Reviewers: Li Liu, MD Source: bladder cancer antigen, and tissue polypeptide antigen) and 1 nuclear matrix assay (NMP22) for the diagnosis of bladder cancer.MethodA total of 111 patients with active bladder cancer, 76 patients with a history of... |
|
|
Gemcitabine and Cisplatin versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
Reviewers: Li Liu, MD Source: Journal of Clinical Oncology, Volume 18:3068-3077, (September) 2000Précis: Gemcitabine plus cisplatin should become the standard for some bladder cancer patientsIntroductionThe standard therapy for many patients with... |
|
|
Phase III Trial of Neoadjuvant Chemotherapy in Patients with Invasive Bladder Cancer Treated with Selective Bladder Preservation by Combined Radiation Therapy and Chemotherapy: Initial Results of Radiation Therapy Oncology Group 89-03
Authors: W.U. Shipley, K.A. Winter, D.S. Kaufman, W.R. Lee, N.M. Heney, W.R. Tester, et al. Source: J Clin Oncol. 1998 Nov; 16(11): 3576-83. Background Multimodality bladder-sparing treatment regimens, consisting of limited surgery,... |
|
|
Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer
Authors: Shipley WU, et al. Source: UROLOGY 60: 62-68, 2002 Background Radical cystectomy remains the standard of care for muscle invasive bladder cancer Formerly, bladder preservation was only attempted in patients with small tumors with... |
|
|
Selective Bladder Preservation by Combined Modality Protocol Treatment: Long-term Results of 190 Patients With Invasive Bladder Cancer
Source: Urology. 2002 Jul;60(1):62-7 Authors: W. U. Shipley, D. S. Kaufman, E. Zehr, N. M. Heney, S. C. Lane, H. K. Thakral, A. F. Althausen, and A. L. Zietman Background The standard of care in the United States for muscle-invasive bladder... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
